Cite
MLA Citation
Garth Cruickshank et al.. “Local Delivery Of Irinotecan To Recurrent Glioblastoma At Reoperation Offers A Safe Therapeutic Advantage Over Systemic Delivery.” Neuro-oncology, vol. 20, n.d., p. i1. http://access.bl.uk/ark:/81055/vdc_100095517140.0x000010